RAPTOR PHARMACEUTICALS
Raptor Pharmaceuticals Corp. operates as a development stage biotechnology company in the United States. The company engages in the discovery, research, and preclinical development of drug candidates and drug-targeting platforms for the treatment of various brain disorders and neurodegenerative diseases, genetic disorders, and cancer through the proprietary use of receptor-associated proteins and mesoderm development proteins. Its clinical-stage products include DR Cysteamine, which is in Phase ... IIb clinical trail for the treatment of nephropathic cystinosis or cystinosis; and in Phase IIa clinical trail for the treatment of non-alcoholic steatohepatitis. The company also develops Convivia, a Phase IIa clinical trail product for the treatment of aldehyde dehydrogenase or ALDH2 deficiency; DR Cysteamine, which is in Phase II clinical trail for the treatment of Huntington's Disease; and Tezampanel and NGX 426 that is in Phase II clinical trail for the treatment of migraine, acute pain, and chronic pain. In addition, its preclinical development products comprise HepTide for the treatment of Hepatocellular Carcinoma and Hepatitis C; WntTide for the treatment of breast cancer; and NeuroTrans for the treatment of neurodegenerative diseases. The company has collaboration agreements with the University of California, San Diego for a clinical study of DR Cysteamine in juvenile patients with Non-Alcoholic Steatohepatitis and to study DR Cysteamine in patients with cystinosis. Raptor Pharmaceuticals Corp was founded in 2005 and is based in Novato, California.
RAPTOR PHARMACEUTICALS
Industry:
Biopharma Biotechnology Genetics Therapeutics
Founded:
2002-04-01
Address:
Novato, California, United States
Country:
United States
Website Url:
http://www.raptorpharma.com
Total Employee:
51+
Status:
Active
Contact:
4153828002
Email Addresses:
[email protected]
Total Funding:
172.89 M USD
Technology used in webpage:
SPF Google Tag Manager Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS JQuery CDN Apache 2.4 Sectigo SSL Sectigo Domain SSL
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-09-29 | TorreyPines Therapeutics | TorreyPines Therapeutics acquired by Raptor Pharmaceuticals | N/A |
Investors List
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Post-IPO Debt - Raptor Pharmaceuticals
Heights Capital Management
Heights Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals
Iroquois Capital
Iroquois Capital investment in Post-IPO Equity - Raptor Pharmaceuticals
Deerfield Capital Management
Deerfield Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Raptor Pharmaceuticals
Official Site Inspections
http://www.raptorpharma.com
- Host name: 206.176.233.40
- IP address: 206.176.233.40
- Location: Petaluma United States
- Latitude: 38.2478
- Longitude: -122.6192
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94954
More informations about "Raptor Pharmaceuticals"
Raptor Pharmaceuticals - Crunchbase Company Profile …
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics. View contacts for Raptor …See details»
Raptor Pharmaceuticals - PitchBook
Provider of bio-pharmaceutical therapies intended to treat diseases that are debilitating and life-threatening. The company's bio-pharmaceutical therapies focuses on developing and …See details»
Raptor Pharmaceutical Corp. - Products, Competitors, Financials ...
Raptor Pharmaceutical Corp. is a global biopharmaceutical company focused on the development and commercialization of transformative therapeutics for rare, debilitating, and often fatal …See details»
Raptor Pharmaceutical - Overview, News & Similar companies
View Raptor Pharmaceutical (www.raptorpharma.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Sep 30, 2009 · Raptor Pharmaceutical Corp. ("the Company") is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics …See details»
Raptor Pharmaceutical Inc. - Novato, USA - bionity.com
Jun 22, 2012 · Raptor Pharmaceuticals Corp.’s business consists of two segments: its 100% ownership of Raptor Pharmaceutical Inc., a development stage biotechnology company which …See details»
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Sep 30, 2009 · /CNW/ -- Raptor Pharmaceuticals Corp. ("Raptor") (OTC Bulletin Board: RPTP) and TorreyPines Therapeutics, Inc. ("TorreyPines") (Nasdaq: TPTX) announced today...See details»
M&A Summary, Ownership, and Business Overview - Mergr
May 23, 2017 · Raptor Pharmaceutical Corp. is a bio pharmaceutical company focused on the development and commercialization of transformative therapeutics for rare, debilitating and …See details»
Raptor Pharmaceutical Inc. and TorreyPines Therapeutics, Inc
Sep 29, 2009 · Raptor Pharmaceuticals Corp. ("Raptor") is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the …See details»
Raptor Pharmaceutical Corp. | Insights
Mercaptor Discoveries , a new drug discovery business founded by research scientists, is striving to get its first compound into clinical testing as a treatment for neurodegenerative disorders …See details»
Raptor Pharmaceutical Expands Board of Directors - Newswire
Oct 1, 2009 · /CNW/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the...See details»
Horizon Pharma to buy Raptor Pharma for $800 mln | Reuters
Sep 12, 2016 · Horizon Pharma Plc
Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic ...
Jun 11, 2009 · Raptor Pharmaceuticals Corp. ("Raptor") is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the …See details»
Raptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for …
Apr 30, 2013 · RaptorCares provides individualized services to help patients access PROCYSBI through education, support, extensive case management and a commitment to the principle …See details»
Raptor Pharmaceuticals To Collaborate With Roche On …
Jun 9, 2009 · Raptor Pharmaceuticals Corp. (Raptor) is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the …See details»
Raptor Pharmaceutical Corp. Announces $7.5 Million ... - Newswire
Dec 18, 2009 · /CNW/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), today announced that it has entered into definitive agreements with...See details»
Horizon Pharma in $800M Raptor rare disease buy, but pipeline …
Sep 12, 2016 · Ireland’s Horizon Pharma ($HZNP) will pay a 21% premium for California-based Raptor Pharmaceutical as it looks to bolster its rare disease portfolio while also expanding its …See details»
What is Raptor Pharmaceuticals? Company Culture, Mission, Values
See what employees say it's like to work at Raptor Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Raptor Pharmaceuticals.See details»
Raptor Pharmaceutical Completes DR Cysteamine Phase 2b
Nov 23, 2009 ·
Raptor plans to meet with the Food and Drug Administration ("FDA") and European Medicines Agency ("EMEA") to discuss the results of its phase 2b study and its …See details»
Monitoring of toxic metals(loids) in fifteen raptor bird species of ...
16 hours ago · Heavy metals enter the environment naturally through processes such as wind erosion of soil, forest fires, volcanic activities, biogenic processes, and release of marine salt …See details»